HPLC Method for Analysis of Bivalirudin and Asp9 – bivalirudin on BIST A+

HPLC Method for Bivalirudin on BIST A+ by SIELC Technologies

HPLC Method for Analysis of Bivalirudin and Asp9 - bivalirudin on BIST A+
HPLC Method for Analysis of Bivalirudin on BIST A+ Column by SIELC Technologies

Bivalirudin is a short, 21-amino-acid peptide with the chemical formula C98H138N24O33.  It has 2 basic and 6 acidic groups. It is sold as a direct thrombin inhibitor (DTI), which is used as an anticoagulant.

Asp9-bivalirudin is a process impurity and can be a result of the degradation of the drug bivalirudin. It has the chemical formula C98H137N23O34.

SIELC’s new BIST™ mode can retain and separate Bivalirudin and its degradant with a TMDAP phosphate buffer, and the respective retention times can be controlled by altering the pH of the buffer.

Condition

ColumnBIST A+, 2.1 x 100 mm, 3 µm, 100 A, dual ended
Mobile PhaseMeCN – 30%
BufferTMDAP phosphate – 5 mM  pH 5.0, pH 6.0
Flow Rate0.2 mL/min
DetectionUV 275 nm

Description

Class of CompoundsDrugs, Anticoagulant
Analyzing CompoundsBivalirudin

Application Column

BIST A+

Column Diameter: 2.1 mm
Column Length: 100 mm
Particle Size: 3 µm
Pore Size: 100 A
Column options: dual ended

Add to cart
Application Analytes:
Bivalirudin

Application Detection:
UV Detection
SIELC Technologies usually develops more than one method for each compound. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound/s of interest.